Demographic data for participant groups
| Group | No. of Patients (Sex) | Age (y) | Diagnosis (MS Subtype) | Disease Duration (y) | EDSS (Range) |
|---|---|---|---|---|---|
| Healthy volunteers | 7 (5 F) | 44 ± 7 | − | − | − |
| All patients with MS | 39 (21 F)a | 49 ± 12 | Relapsing-remitting (n = 14) | 13 ± 11 | 1.0–7.0 |
| Secondary-progressive (n = 10) | |||||
| Primary-progressive (n = 15) | |||||
| MS subgroup for quantitative analysis | 10 (9 F) | 47 ± 12 | Relapsing-remitting (n = 4) | 17 ± 14 | 1.0–6.5 |
| Secondary-progressive (n = 5) | |||||
| Primary-progressive (n = 1) |
↵a One of 40 patients recruited was dropped from the analysis when clinically diagnosed with neuromyelitis optica.